Claudia Percivalle is a global regulatory affair professional with broad experience across various regulatory aspects and therapeutic areas including cardiovascular, rare diseases, and neurology. For close to past 10 years, Claudia successfully led global teams in small and large pharma companies for early development (CTA/IND) and late development/ product lifecycle (MAA/NDA/ANDAs/sNDAs) projects for EU, North America, MENA, and APAC markets. In her current role as Regulatory Affairs Director at AstraZeneca, she provides strategic directions to project teams within their CVRM portfolio. Previously, she served as Head of Regulatory Affairs & Clinical Development at Cycle Pharmaceuticals Ltd. Claudia holds a PhD in organic chemistry and has published her research in prestigious chemistry peer-reviewed journals.